Effects of tumour necrosis factor-α in the human forearm: Blood flow and endothelin-I release

Clinical Science

Volumn 103, Issue 4, 2002, Pages 409-415

  Patel, Jigisha N ^a   Jager, A ^a   Schalkwijk, C ^a   Corder, R ^a   Douthwaite, J A ^a   Yudkin, J S ^a   Coppack, S W ^a   Stehouwer, C D A ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Acetylcholine; Cytokine; Endothelial function; Endothelin 1 (ET 1); Interleukin 6; Sodium nitroprusside; Tumour necrosis factor (TNF )

Indexed keywords

ACETYLCHOLINE; ENDOTHELIN 1; NITROPRUSSIDE SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD VESSEL TONE; BRACHIAL ARTERY; FEMALE; FOREARM BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; VASCULAR ENDOTHELIUM; VASODILATATION; VENOUS BLOOD;

EID: 0036797913     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs1030409     Document Type: Article

References (33)

1. Endo, S., Inada, K., Yamada, Y. et al. (1996) Functional modification of vascular endothelial cells by cytokines during septic shock. Res. Commun. Mol. Pathol. Pharmacol. 94, 23-38
2. Bhagat, K. and Vallance, P. (1999) Effects of cytokines on nitric oxide pathways in human vasculature. Curr. Opin. Nephrol. Hypertens. 8, 89-96
3. Mishima, Y., Kuyama, A., Tada, A., Takahashi, K., Ishioka, T. and Kibata, M. (2001) Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 52, 119-123
4. Katsuki, A., Sumida, Y., Murashima, S. et al. (1998) Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 83, 859-862
5. Tappia, P. S., Troughton, K. L., Langley-Evans, S. C. and Grimble, R. F. (1995) Cigarette smoking influences cytokine production and antioxidant defences. Clin. Sci. 88, 485-489
6. Vemulapalli, S., Chiu, P.J., Griscti, K., Brown, A., Kurowski, S. and Sybertz, E. J. (1994) Phosphoramidon does not inhibit endogenous endothelin-1 release stimulated by hemorrhage, cytokines and hypoxia in rats. Eur. J. Pharmacol. 257, 95-102
7. Corder, R., Carrier, M., Khan, N., Klemm, P. and Vane, J. R. (1995) Cytokine regulation of endothelin-1 release from bovine aortic endothelial cells. J. Cardiovasc. Pharmacol. 26 (Suppl. 3), S56-S58
8. Marsden, P. A. and Brenner, B. M. (1992) Transcriptional regulation of the endothelin-1 gene by TNF-α. Am. J. Physiol. 262, C854-C861
9. Kruse-Elliott, K. T., Whorton, A. R. and Olson, N. C. (1998) Role of lipid-derived mediators in tumor necrosis factor-induced endothelin-1 release in vivo. Shock 9, 40-45
10. Hohlfeld, T., Klemm, P., Thiemermann, C., Warner, T. D., Schror, K. and Vane, J. R. (1995) The contribution of tumour necrosis factor-α and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin. Br. J. Pharmacol. 116, 3309-3315
11. Klemm, P., Warner, T. D., Hohlfeld, T., Corder, R. and Vane, J. R. (1995) Endothelin 1 mediates ex vivo coronary vasoconstriction caused by exogenous and endogenous cytokines. Proc. Natl. Acad. Sci. U.S.A. 92, 2691-2695
12. Kelly, J. J. and Whitworth, J. A. (1999) Endothelin-1 as a mediator in cardiovascular disease. Clin. Exp. Pharmacol. Physiol. 26, 158-161
13. Wang, P., Ba, Z. F. and Chaudry, I. H. (1994) Administration of tumor necrosis factor-α in vivo depresses endothelium-dependent relaxation. Am. J. Physiol 266, H2535-H2541
14. Chowienczyk, P. J., Cockcroft, J. R. and Ritter, J. M. (1994) Blood flow responses to intra-arterial acetylcholine in man: effects of basal flow and conduit vessel length. Clin. Sci. 87, 45-51
15. Benjamin, N., Calver, A., Collier, J., Robinson, B., Vallance, P. and Webb, D. (1995) Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 25, 918-923
16. Ammit, A. J., Hoffman, R. K., Amrani, Y. et al. (2000) Tumor necrosis factor-α-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate. Am. J. Respir. Cell Mol. Biol. 23, 794-802
17. Gasic, S., Tian, B. and Green, A. (1999) Tumor necrosis factor alpha stimulates lipolysis in adipocytes by decreasing Gi protein concentrations. J. Biol. Chem. 274, 6770-6775
18. Ciaraldi, T. P., Carter, L., Mudaliar, S., Kern, P. A. and Henry, R. R. (1998) Effects of tumor necrosis factor-alpha on glucose metabolism in cultured human muscle cells from nondiabetic and type 2 diabetic subjects. Endocrinology 139, 4793-4800
19. Conahan, III, T. J., Schwartz, A. J. and Geer, R. T. (1977) Percutaneous catheter introduction: the Seldinger technique. JAMA, J. Am. Med. Assoc. 237, 446-447
20. Whitney, R. J. (1953) The measurement of volume changes in human limbs. J. Physiol. (London) 121, 1-27
21. Saks, S. and Rosenblum, M. (1992) Recombinant human TNF-α: preclinical studies and results from early clinical trials. Immunol. Ser. 56, 567-587
22. Coppack, S. W., Evans, R. D., Fisher, R. M. et al. (1992) Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metab. Clin. Exp. 41, 264-272
23. Gamm, H., Lindemann, A., Mertelsmann, R. and Herrmann, F. (1991) Phase I trial of recombinant human tumour necrosis factor alpha in patients with advanced malignancy. Eur. J. Cancer 27, 856-863
24. Hollenberg, S. M., Cunnion, R. E. and Parrillo, J. E. (1991) The effect of tumor necrosis factor on vascular smooth muscle. In vitro studies using rat aortic rings. Chest 100, 1133-1137
25. Brian, Jr, J. E. and Faraci, F. M. (1998) Tumor necrosis factor-alpha-induced dilatation of cerebral arterioles. Stroke 29, 509-515
26. MacNaul, K. L. and Hutchinson, N. I. (1993) Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem. Biophys. Res. Commun. 196, 1330-1334
27. Simper, D., Strobel, W. M., Linder, L. and Haefeli, W. E. (1995) Indirect evidence for stimulation of nitric oxide release by tumour necrosis factor-alpha in human veins in vivo. Cardiovasc. Res. 30, 960-964
28. Bhagat, K., Hingorani, A. D., Palacios, M., Charles, I. G. and Vallance, P. (1999) Cytokine-induced venodilatation in humans in vivo: eNOS masquerading as iNOS. Cardiovasc. Res. 41, 754-764
29. Bhagat, K. and Vallance, P. (1997) Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 96, 3042-3047
30. Vemulapalli, S., Chiu, P. J., Rivelli, M., Foster, C. J. and Sybertz, E. J. (1991) Modulation of circulating endothelin levels in hypertension and endotoxemia in rats. J. Cardiovasc. Pharmacol. 18, 895-903
31. Harrison, V. J., Barnes, K., Turner, A. J., Wood, E., Corder, R. and Vane, J. R. (1995) Identification of endothelin-1 and big endothelin-1 in secretory vesicles isolated from bovine aortic endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 92, 6344-6348
32. Corder, R. (2001) Identity of endothelin-converting enzyme and other targets for the therapeutic regulation of endothelin biosynthesis. Handb. Exp. Pharmacol. 152, 35-67
33. Shaw, J. A., Chin-Dusting, J. P., Kingwell, B. A. and Dart, A. M. (2001) Diurnal variation in endothelium-dependent vasodilatation is not apparent in coronary artery disease. Circulation 103, 806-812